vs
Side-by-side financial comparison of Cipher Mining Inc. (CIFR) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $59.7M, roughly 1.0× Cipher Mining Inc.). Cytek Biosciences, Inc. runs the higher net margin — -70.9% vs -1229.6%, a 1158.7% gap on every dollar of revenue. On growth, Cipher Mining Inc. posted the faster year-over-year revenue change (41.4% vs 8.1%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-695.9M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 11.4%).
Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CIFR vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $59.7M | $62.1M |
| Net Profit | $-734.2M | $-44.1M |
| Gross Margin | 59.4% | 52.9% |
| Operating Margin | -503.4% | -9.0% |
| Net Margin | -1229.6% | -70.9% |
| Revenue YoY | 41.4% | 8.1% |
| Net Profit YoY | -4293.1% | -557.1% |
| EPS (diluted) | $-1.91 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $59.7M | $62.1M | ||
| Q3 25 | $71.7M | $52.3M | ||
| Q2 25 | $43.6M | $45.6M | ||
| Q1 25 | $49.0M | $41.5M | ||
| Q4 24 | $42.2M | $57.5M | ||
| Q3 24 | $24.1M | $51.5M | ||
| Q2 24 | $36.8M | $46.6M | ||
| Q1 24 | $48.1M | $44.9M |
| Q4 25 | $-734.2M | $-44.1M | ||
| Q3 25 | $-3.3M | $-5.5M | ||
| Q2 25 | $-45.8M | $-5.6M | ||
| Q1 25 | $-39.0M | $-11.4M | ||
| Q4 24 | $17.5M | $9.6M | ||
| Q3 24 | $-86.8M | $941.0K | ||
| Q2 24 | $-15.3M | $-10.4M | ||
| Q1 24 | $39.9M | $-6.2M |
| Q4 25 | 59.4% | 52.9% | ||
| Q3 25 | 62.7% | 52.7% | ||
| Q2 25 | 64.8% | 52.3% | ||
| Q1 25 | 69.6% | 48.6% | ||
| Q4 24 | 56.9% | 58.5% | ||
| Q3 24 | 37.5% | 56.3% | ||
| Q2 24 | 61.2% | 54.6% | ||
| Q1 24 | 69.2% | 51.3% |
| Q4 25 | -503.4% | -9.0% | ||
| Q3 25 | -52.5% | -17.6% | ||
| Q2 25 | -103.9% | -23.3% | ||
| Q1 25 | -77.8% | -36.1% | ||
| Q4 24 | 40.5% | 5.2% | ||
| Q3 24 | -379.2% | -8.2% | ||
| Q2 24 | -43.9% | -18.3% | ||
| Q1 24 | 97.2% | -23.9% |
| Q4 25 | -1229.6% | -70.9% | ||
| Q3 25 | -4.6% | -10.5% | ||
| Q2 25 | -105.1% | -12.2% | ||
| Q1 25 | -79.6% | -27.5% | ||
| Q4 24 | 41.5% | 16.8% | ||
| Q3 24 | -359.9% | 1.8% | ||
| Q2 24 | -41.5% | -22.4% | ||
| Q1 24 | 82.9% | -13.8% |
| Q4 25 | $-1.91 | — | ||
| Q3 25 | $-0.01 | — | ||
| Q2 25 | $-0.12 | — | ||
| Q1 25 | $-0.11 | — | ||
| Q4 24 | $0.04 | — | ||
| Q3 24 | $-0.26 | — | ||
| Q2 24 | $-0.05 | — | ||
| Q1 24 | $0.13 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $628.3M | $90.9M |
| Total DebtLower is stronger | $2.7B | — |
| Stockholders' EquityBook value | $805.5M | $341.7M |
| Total Assets | $4.3B | $461.5M |
| Debt / EquityLower = less leverage | 3.37× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $628.3M | $90.9M | ||
| Q3 25 | $1.2B | $93.3M | ||
| Q2 25 | $62.7M | $75.5M | ||
| Q1 25 | $23.2M | $95.3M | ||
| Q4 24 | $5.6M | $98.7M | ||
| Q3 24 | $25.3M | $162.3M | ||
| Q2 24 | $122.6M | $177.9M | ||
| Q1 24 | $88.7M | $168.8M |
| Q4 25 | $2.7B | — | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $167.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $805.5M | $341.7M | ||
| Q3 25 | $783.2M | $378.6M | ||
| Q2 25 | $748.9M | $377.6M | ||
| Q1 25 | $734.8M | $379.6M | ||
| Q4 24 | $682.0M | $395.7M | ||
| Q3 24 | $672.0M | $385.5M | ||
| Q2 24 | $690.8M | $389.1M | ||
| Q1 24 | $600.9M | $392.6M |
| Q4 25 | $4.3B | $461.5M | ||
| Q3 25 | $2.8B | $494.9M | ||
| Q2 25 | $1.0B | $493.3M | ||
| Q1 25 | $913.8M | $482.6M | ||
| Q4 24 | $855.4M | $499.5M | ||
| Q3 24 | $775.4M | $491.2M | ||
| Q2 24 | $775.6M | $483.7M | ||
| Q1 24 | $677.1M | $492.1M |
| Q4 25 | 3.37× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 0.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-207.9M | $-771.0K |
| Free Cash FlowOCF − Capex | $-695.9M | $-1.8M |
| FCF MarginFCF / Revenue | -1165.4% | -2.9% |
| Capex IntensityCapex / Revenue | 817.1% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.1B | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-207.9M | $-771.0K | ||
| Q3 25 | $-50.1M | $-3.9M | ||
| Q2 25 | $-56.2M | $108.0K | ||
| Q1 25 | $-47.2M | $-125.0K | ||
| Q4 24 | $-87.5M | $2.0M | ||
| Q3 24 | $-6.5M | $13.2M | ||
| Q2 24 | $-25.4M | $6.2M | ||
| Q1 24 | $-26.6M | $4.0M |
| Q4 25 | $-695.9M | $-1.8M | ||
| Q3 25 | $-256.2M | $-4.6M | ||
| Q2 25 | $-87.5M | $-1.5M | ||
| Q1 25 | $-71.8M | $-974.0K | ||
| Q4 24 | $-227.0M | $1.1M | ||
| Q3 24 | $-83.2M | $12.2M | ||
| Q2 24 | $-33.2M | $5.2M | ||
| Q1 24 | $-34.5M | $3.4M |
| Q4 25 | -1165.4% | -2.9% | ||
| Q3 25 | -357.3% | -8.7% | ||
| Q2 25 | -200.9% | -3.2% | ||
| Q1 25 | -146.7% | -2.3% | ||
| Q4 24 | -537.6% | 1.9% | ||
| Q3 24 | -345.0% | 23.7% | ||
| Q2 24 | -90.2% | 11.0% | ||
| Q1 24 | -71.7% | 7.6% |
| Q4 25 | 817.1% | 1.6% | ||
| Q3 25 | 287.5% | 1.3% | ||
| Q2 25 | 71.8% | 3.5% | ||
| Q1 25 | 50.2% | 2.0% | ||
| Q4 24 | 330.4% | 1.6% | ||
| Q3 24 | 317.8% | 2.0% | ||
| Q2 24 | 21.4% | 2.3% | ||
| Q1 24 | 16.4% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -5.00× | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.67× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CIFR
Segment breakdown not available.
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
